Riskpilot← Back to searchSign inGet full accessNACAMED AS
ASActiveOrg 918850317Rakkestadveien 1, 1814 AskimResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20173 employees
Revenue 2024
NOK 3,1M
-36% vs 2023
EBITDA margin
41.0%
+165% vs 2023
Equity ratio
63.3%
Financial strength
Net profit 2024
NOK 1,3M
+167% vs 2023
| Revenue | NOK 3,1M | -36% |
| EBITDA | NOK 1,3M | +165% |
| Net profit | NOK 1,3M | +167% |
| Total assets | NOK 5,6M | +55% |
| Equity | NOK 3,6M | +57% |
| Employees | 3 | — |
Legal name
NACAMED AS
Org number
918850317
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11. april 2017
Share capital
NOK 136 588
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Utvikling og kommersiell utnyttelse av tekniske innretninger, produksjon for legemiddelindustri, handel, service og annet som naturlig faller sammen med dette.
Address
Rakkestadveien 1, 1814 Askim
Email
cwh@nacamed.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 224 | 2 156 | 3 285 | 2 920 | 2 697 | 5 096 | 4 915 | 3 147 |
| Staff expenses | −0 | −0 | −167 | −861 | −1 641 | −2 609 | −2 987 | −1 748 |
| EBITDA | −45 | −2 437 | −4 285 | −1 635 | −1 251 | −581 | −1 990 | 1 292 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −36 |
| EBIT | −45 | −2 437 | −4 285 | −1 635 | −1 251 | −581 | −1 990 | 1 256 |
| Net financials | 0 | 2 | 14 | −75 | 3 | 40 | 56 | 34 |
| Profit before tax | −44 | −2 435 | −4 271 | −1 710 | −1 248 | −541 | −1 934 | 1 290 |
| Tax | −57 | −1 028 | −1 692 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 12 | −1 406 | −2 579 | −1 710 | −1 248 | −541 | −1 934 | 1 290 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 690 | 7 999 | 5 539 | 2 355 | 5 147 | 3 613 | 3 626 | 5 635 |
| Equity | 512 | 3 606 | 1 027 | −683 | 2 751 | 2 210 | 2 277 | 3 567 |
| Long-term debt | 0 | 300 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 178 | 4 094 | 4 512 | 3 038 | 2 396 | 1 403 | 1 349 | 2 067 |
| Total debt | 178 | 4 394 | 4 512 | 3 038 | 2 396 | 1 403 | 1 349 | 2 067 |
EBITDA margin
41.0%
This company
15.8%
Market median
+159% vs market
20172024
Equity ratio
63.3%
This company
38.2%
Market median
+66% vs market
20172024
Return on equity
36.2%
This company
18.4%
Market median
+97% vs market
20172024
Net profit margin
41.0%
This company
8.1%
Market median
+406% vs market
20172024
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
20172024
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-03-23 – 2017-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Æsop As | Company | 43.9% | 43.9% | 2024 |
| Individual | 22.0% | 22.0% | 2024 | |
Hlberger As | Company | 7.3% | 7.3% | 2024 |
Nils Lemming Consulting As | Company | 6.2% | 6.2% | 2024 |
Dynatec Engineering As | Company | 5.7% | 5.7% | 2024 |
Aanerød As | Company | 5.2% | 5.2% | 2024 |
Tw Capital As | Company | 4.8% | 4.8% | 2024 |
Fledsberg Finans As | Company | 2.2% | 2.2% | 2024 |
Akershus Teknologifond As | Company | 1.6% | 1.6% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NACAMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Gunnar Fledsberg | Board of Directors | 0 companies |
| Christina Cecilie Hendrika Westerveld Haug | Chairman | 0 companies |
| Josef Filtvedt | Board of Directors | 0 companies |
| Helge Lars Berger | Board of Directors | 0 companies |
| Nils Lemming | Chairman | 0 companies |